Works matching IS 17582652 AND DT 2010 AND VI 13 AND IP Suppl 4

Results: 286

Fracture risk in HIV and the need for guidelines: the Probono-1 Trial.
Published in:
2010
By:
- Peters, B.;
- Isohanni, H.;
- Tillet, S.;
- Ibrahim, F.;
- Hampson, G.;
- Williams, F. M. K.;
- Perry, M. E. O.;
- Duncan, A.;
- Wierzbicki, A.
Publication type:
Abstract
Quantitative ultrasound (QUS) in HIV-infected patients: a reliable and low-cost technique for bone health assessment.
Published in:
2010
By:
- Marocco, R.;
- Martini, H.;
- Belvisi, V.;
- Tieghi, T.;
- Cesareo, R.;
- Del Borgo, C.;
- Lichtner, M.;
- Mastroianni, C. M.
Publication type:
Abstract
Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance used.
Published in:
2010
By:
- Piso, R. J.;
- Rothen, M.;
- Rothen, J. P.;
- Stahl, M.
Publication type:
Abstract
Lack of association between mitochondrial DNA polymorphisms and didexoxynucleoside-induced hyperlactataemia in black-African, HIV-1-infected patients.
Published in:
2010
By:
- Arenas-Pinto, A.;
- Weller, I.;
- Ekong, R.;
- Grant, A.;
- Karstaedt, A.;
- Telisinghe, L.;
- Bolhaar, M.;
- Charalambous, S.;
- Bradman, N.;
- Ingram, C.
Publication type:
Abstract
Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline.
Published in:
2010
By:
- de Jong, E.;
- Haverkort, M. E.;
- Heine, R. ter;
- Jansen, R. S.;
- Beijnen, J. H.;
- van Agtmael, M. A.
Publication type:
Abstract
A case of nodular regenerative hyperplasia in a patient who had been taking didanosine.
Published in:
2010
By:
- Jackson, C.;
- Fox, R.;
- Priest, M.;
- Clutterbuck, D.;
- Peters, E.
Publication type:
Abstract
Clinical significance of hyperbilirubinemia in the CASTLE study.
Published in:
2010
By:
- Uy, J.;
- Hu, W.;
- Wirtz, V.;
- Hosey, T.;
- Butcher, D.;
- McGrath, D.;
- Farajallah, A.
Publication type:
Abstract
Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection.
Published in:
2010
By:
- Mendeni, M.;
- Focà, E.;
- Gotti, D.;
- Ladisa, N.;
- Quiros-Roldan, E.;
- Vavassori, A.;
- Castelnuovo, F.;
- Carosi, G.;
- Angarano, G.;
- Torti, C.
Publication type:
Abstract
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients.
Published in:
2010
By:
- Macías, J.;
- Mallolas, J.;
- López-Cortés, L. F.;
- Cartón, J. A.;
- Domingo, P.;
- Moreno, S.;
- Iribarren, J. A.;
- Neukam, K.;
- Rodrigo, A.;
- Jiménez-Expósito, M. J.;
- Pineda, J. A.
Publication type:
Abstract
Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin.
Published in:
2010
By:
- Mankhatitham, W.;
- Lueangniyomkul, A.;
- Manosuthi, W.
Publication type:
Abstract
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug.
Published in:
2010
By:
- Billaud, E.;
- Lacombe, J. M.;
- Abgrall, A.;
- Ghosn, J.;
- Launay, O.;
- Livrozet, J. M.;
- Meynard, J. L.;
- Pavie, J.;
- Costagliola, D.
Publication type:
Abstract
Prevalence of chronic renal failure stage 3 or more in HIV-infected patients in Antwerp: an observational study.
Published in:
2010
By:
- Colson, A. W.;
- Florence, E.;
- Augustijn, H.;
- Verpooten, G. A.;
- Lynen, L.;
- Gheuens, E.
Publication type:
Abstract
The association between metabolic syndrome and the occurrence of nephrolithiasis in HIV-infected patients.
Published in:
2010
By:
- Dumitru, I. M.;
- Rugina, S.;
- Sotila, G.;
- Dumitru, E.;
- Rugina, C. N.
Publication type:
Abstract
Intracellular tenofovir-diphosphate accumulation in an HIV-infected patient with Fanconi syndrome and osteomalacia.
Published in:
Journal of the International AIDS Society, 2010, v. 13, n. Suppl 4, p. 1, doi. 10.1186/1758-2652-13-S4-P87
By:
- Haverkort, M. E.;
- van der Spek, B. W.;
- Lips, P. T.;
- Slieker, W. A. T.;
- Bronsveld, W.
Publication type:
Article
The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART).
Published in:
2010
By:
- Cassetti, I.;
- Etzel, A.;
- Madruga, J. V.;
- Suleiman, J. M.;
- Zhou, Y.;
- Rhee, M.;
- Warren, D. R.
Publication type:
Abstract
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial).
Published in:
2010
By:
- Izzo, I.;
- Albini, L.;
- Calabresi, A.;
- Motta, D.;
- Bellagamba, R.;
- Fezza, R.;
- Narciso, P.;
- Sighinolfi, L.;
- Maggi, P.;
- Focà, E.;
- Mendeni, M.;
- Manili, L.;
- Magoni, M.;
- Carosi, G.;
- Quiros-Roldan, E.;
- Torti, C.
Publication type:
Abstract
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART.
Published in:
2010
By:
- Uglietti, A.;
- Gervasoni, C.;
- Gabrielli, E.;
- Di Giambenedetto, S.;
- Cauda, R.;
- Esposito, R.;
- Grima, P.;
- Di Perri, G.;
- Maserati, R.;
- Galli, M.
Publication type:
Abstract
Kidney tubular function and serum phosphate levels in HIV-1-infected patients treated with tenofovir: preliminary results.
Published in:
2010
By:
- Grima, P.;
- Zizza, A.;
- Calabrese, P.;
- Chiavaroli, R.;
- Faraone, A.;
- Tana, M.;
- Sodo, M. R.;
- Tundo, P.;
- Guido, M.
Publication type:
Abstract
Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA.
Published in:
2010
By:
- Ryom, L.;
- Mocroft, A.;
- Reiss, P.;
- Ledergerber, B.;
- De Wit, S.;
- Duiculescu, D.;
- Monforte, A. D.;
- Murphy, M.;
- Lundgren, J. D.;
- Kirk, O.
Publication type:
Abstract
CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years.
Published in:
2010
By:
- Podzamczer, D.;
- Tiraboschi, J. M.;
- Mallolas, J.;
- Cárdenes, M. A.;
- Casas, E.;
- Castro, A.;
- Echevarria, S.;
- Leal, M.;
- de Quirós, J. C. Lopez Bernanldo;
- Moreno, S.;
- Puig, T.;
- Ribera, E.;
- Villalonga, C.;
- Sirvent, J. L. Gomez;
- Heranejos, J. A. Garcia;
- Lopez-Aldeguer, J.;
- Barrufet, P.;
- Force, L.;
- Santos, I.;
- Sanz, J.
Publication type:
Abstract
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study.
Published in:
2010
By:
- Moyle, G.;
- Orkin, C.;
- Fisher, M.;
- Anderson, J.;
- Dhar, J.;
- Wang, M. H.;
- Ewan, J.
Publication type:
Abstract
HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC).
Published in:
2010
By:
- Baran, R. W.;
- Dietz, B.;
- Fredrick, L. M.;
- Tian, M.;
- Podsadecki, T.
Publication type:
Abstract
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study).
Published in:
2010
By:
- Rodriguez, J. M.;
- Delgado, M.;
- Viciana, P.;
- Lopez-Ruz, M. A.;
- Leal, M.;
- Alcacer, F.;
- Deig, E.;
- Antela, A.;
- Pedrol, E.;
- Moreno, S.
Publication type:
Abstract
Altered phosphate metabolism in HIV-1-infected patients: another feature of metabolic syndrome?
Published in:
2010
By:
- Grima, P.;
- Zizza, A.;
- Guido, M.;
- Calabrese, P.;
- Chiavaroli, R.;
- Sodo, M. R.;
- Tana, M.;
- Tundo, P.
Publication type:
Abstract
Dietician-based approach to lipodystrophic syndrome: role of bioelectrical impedance analysis at week 12.
Published in:
2010
By:
- Orofino, G.;
- Guastavigna, M.;
- Martinoglio, P.;
- Penoncelli, D.;
- Demarie, D.;
- Tettoni, M.;
- Desiderato, P.;
- Di Frenna, R.;
- Zignin, C.
Publication type:
Abstract
Nutritional status in HIV-infected patients using Changi's mini nutritional assessment.
Published in:
2010
By:
- Cervero, M.;
- Alcázar, V.;
- Sanz, R.;
- Calle, C. García-La;
- Agud, J. L.
Publication type:
Abstract
Adiponectin and leptin levels in HIV-infected patients with lipodystrophy in Southern India.
Published in:
2010
By:
- Jacob, S. Mini;
- Phoebe, K. Annie;
- Hemalatha, R.;
- Sivakumar, M. R.;
- Ravindran, M. P.;
- Natarajan, M. V.
Publication type:
Abstract
Metabolic: week 48 comparison of METABOLIK parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir.
Published in:
2010
By:
- Overton, T.;
- Aberg, J. A.;
- Gupta, S.;
- Ryan, R.;
- Baugh, B.;
- De La Rosa, G.
Publication type:
Abstract
Hypertriglyceridemic waist identifies HIV+ men and women at increased cardiometabolic risk.
Published in:
2010
By:
- Guaraldi, G.;
- Zona, S.;
- Orlando, G.;
- Carli, F.;
- Stentarelli, C.;
- Despres, J.;
- Ross, R.
Publication type:
Abstract
Mesenteric fat thickness in a group of HIV patients on HAART.
Published in:
2010
By:
- Lee, S. S.;
- Liu, E.;
- To, K. W.
Publication type:
Abstract
Lipodystrophy and metabolic syndrome in Romanian HIV-infected adults.
Published in:
2010
By:
- Arbune, M.
Publication type:
Abstract
Alexithymia, an impairment of emotional cognitive processing, is a candidate risk factor for carotid artery plaque formation in HIV-infected patients.
Published in:
2010
By:
- Vadini, F.;
- Sozio, F.;
- Mazzotta, E.;
- Agostinone, C.;
- Ursini, T.;
- Agostinone, A.;
- Placido, G.;
- Manzoli, L. M.;
- Parruti, G.
Publication type:
Abstract
SUPPORT: 48-week results of fosamprenavir/ ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients.
Published in:
2010
By:
- Kumar, P.;
- DeJesus, E.;
- Huhn, G.;
- Sloan, L.;
- Garcia, F.;
- Small, C.;
- Edelstein, H.;
- Felizarta, F.;
- Hao, R.;
- Ha, B.;
- Stancil, B.;
- Ross, L.;
- Oie, K.;
- Pappa, K.
Publication type:
Abstract
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients.
Published in:
2010
By:
- Puerta, S.;
- Gallego, M.;
- Palacios, R.;
- Ruiz, J.;
- Nuño, E.;
- Márquez, M.;
- Santos, J.
Publication type:
Abstract
Nitric oxide protects against HIV gp120 endothelial injury.
Published in:
2010
By:
- Fiorucci, S.;
- Mencarelli, A.;
- Francisci, D.;
- Distrutti, E.;
- Renga, B.;
- Baldelli, F.
Publication type:
Abstract
Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates.
Published in:
2010
By:
- Golf, J. P.;
- Sala, L.;
- Aramburo, J.;
- Sardà, P.;
- Perez-Alvarez, N.;
- Llibre, J. M.
Publication type:
Abstract
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients.
Published in:
2010
By:
- Grima, P.;
- Guido, M.;
- Chiavaroli, R.;
- Tundo, P.;
- Zizza, A.
Publication type:
Abstract
Incidence of ischemic cardiovascular events in the maraviroc clinical development program.
Published in:
2010
By:
- Portsmouth, S.;
- Burnside, R.;
- Lazzarin, A.;
- Johnson, M.;
- Valdez, H.
Publication type:
Abstract
Cardiovascular risk in patients visiting the Hadassah AIDS Center, Jerusalem.
Published in:
2010
By:
- Schulman, S.;
- Rotshild, V.;
- Pops, K. Olshtein;
- Korem, M.;
- Israel, S.;
- Hauzi, M.;
- Maayan, S.
Publication type:
Abstract
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy.
Published in:
2010
By:
- Palacios, R.;
- González-Correa, J. A.;
- Ruiz, J.;
- Nuño, E.;
- Márquez, M.;
- de la Cruz, J. P.;
- Santos, J.
Publication type:
Abstract
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir.
Published in:
2010
By:
- Francisci, D.;
- Falcinelli, E.;
- Belfiori, B.;
- Petito, E.;
- Mezzasoma, M.;
- Baldelli, F.;
- Gresele, P.
Publication type:
Abstract
Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection.
Published in:
2010
By:
- Kaminskiy, G. D.;
- Pronin, A. J.
Publication type:
Abstract
Long-term efficacy and safety of low-dose ritonavir-boosted atazanavir (ATV/r) 200/100 mg in HIV-infected Thai patients.
Published in:
2010
By:
- Avihingsanon, A.;
- Apornpong, T.;
- Kerr, S. J.;
- Ananworanich, J.;
- Ruxrungtham, K.
Publication type:
Abstract
5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF).
Published in:
2010
By:
- Lazzarin, A.;
- Johnson, M.;
- Ribera, E.;
- Weitner, L.;
- Chen, S. S.;
- Warren, D. R.
Publication type:
Abstract
A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens.
Published in:
2010
By:
- Qaqish, R.;
- van Wyk, J.;
- King, M. S.
Publication type:
Abstract
British HIV and ageing study. HIV and ageing: older people with HIV, who are they?
Published in:
2010
By:
- Allan, S.;
- Daly, R. A.;
- Yoganathan, Y.;
- Barrett, S.;
- Joseph, A.;
- Tariq, A.;
- Saing, C. W.;
- Williams, C.;
- Lane, C.;
- Sikorska, J.
Publication type:
Abstract
Prediction of virological failure in HIV-infected individuals treated with cART in Suriname.
Published in:
2010
By:
- Bleijenberg, M. P.;
- Bierman, W. F. W.;
- Jaglall, C.;
- Heymans, M. W.;
- Doesschate, M. C. ten;
- Nieuwkerk, P. T.;
- Smits, P. H.;
- van Eer, M.;
- Vreden, S.
Publication type:
Abstract
Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir.
Published in:
2010
By:
- Garvey, L. J.;
- Higgs, C.;
- Mohammed, P.;
- Nelson, M.;
- Winston, A.
Publication type:
Abstract
The prognosis of patients with dissociated virological and immunological responses to HAART.
Published in:
2010
By:
- Jevtovic, D. J.;
- Salemovic, D. R.;
- Ranin, J. T.
Publication type:
Abstract
Treatment of HIV-2 infection: a retrospective study from a Portuguese center.
Published in:
2010
By:
- Marques, N.;
- Seixas, D.;
- Crespo, P.;
- Malcata, L.;
- Vaz, J.;
- Mota, V.;
- Morais, C.;
- Oliveira, J.;
- Duque, V.;
- da Cunha, J. Saraiva;
- Meliço-Silvestre, A.
Publication type:
Abstract